Skip to main content

Dextrose and Sodium Chloride

NDC 63323-869 · Fresenius Kabi USA, LLC

Generic nameDEXTROSE MONOHYDRATE and SODIUM CHLORIDE
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)DEXTROSE MONOHYDRATE, SODIUM CHLORIDE
Strength5; .45 g/100mL; g/100mL
Pharmacologic classIncreased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
Marketing categoryANDA

Packages

63323-869-10 — 10 BAG in 1 CASE (63323-869-10) / 1000 mL in 1 BAG (63323-869-01)

63323-869-74 — 20 BAG in 1 CASE (63323-869-74) / 500 mL in 1 BAG (63323-869-04)

63323-869-75 — 30 BAG in 1 CASE (63323-869-75) / 250 mL in 1 BAG (63323-869-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63323-624 — Dextrose Monohydrate, 63323-626 — SODIUM CHLORIDE, 63323-632 — SODIUM CHLORIDE, 63323-667 — Potassium Chloride, Dextrose Monohydrate, 63323-669 — Potassium Chloride, Dextrose Monohydrate, 63323-683 — Sodium Chloride and Potassium Chloride, 63323-686 — Sodium Chloride and Potassium Chloride, 63323-688 — Sodium Chloride and Potassium Chloride, 63323-824 — Dextrose Monohydrate, 63323-867 — DEXTROSE MONOHYDRATE and SODIUM CHLORIDE, 63323-870 — DEXTROSE MONOHYDRATE and SODIUM CHLORIDE, 63323-873 — DEXTROSE MONOHYDRATE and SODIUM CHLORIDE, 63323-874 — DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, 63323-924 — SODIUM CHLORIDE, 63479-0705 — ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR, 63479-2505 — ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR, 63941-704 — Nasal, 64253-202 — SODIUM CHLORIDE, 64380-765 — Polyethylene Glycol 3350 and electrolytes - Unflavored, 64380-766 — Polyethylene Glycol 3350 and electrolytes with Lemon Flavor, +675 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels